FDA Needs Rule Change For DMAA Crackdown, Suit Says

Law360, New York (November 07, 2013, 2:38 PM ET) -- A weight loss and energy supplement maker hit the U.S. Food and Drug Administration with a lawsuit on Tuesday that accuses it of improperly issuing a detention order on products that contain a controversial stimulant, saying the agency must first go through a formal rule-making process.

Georgia-based Hi-Tech Pharmaceuticals Inc. said in its complaint, filed in D.C. federal court, that the FDA has not engaged in the rule-making process necessary to formally ban the stimulant dimethylamylamine, or DMAA, but still issued an administrative detention order against...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

v. HI-TECH PHARMACEUTICALS, INC., A GEORGIA CORPORATION et al


Case Number

1:13-cv-01747

Court

District Of Columbia

Nature of Suit

Administrative Procedure Act/Review or Appeal of Agency Decision

Judge

Ketanji Brown Jackson

Date Filed

November 4, 2013

Law Firms

Companies

Government Agencies